What TRIUMPH-1 Actually Reported TRIUMPH-1 randomized 2,339 adults with obesity (BMI 30) or overweight with at least one weight-related comorbidity, without diabetes, 1:1:1:1 across three retatrutide doses and placebo
Targeted movements for constipation relief Certain exercises specifically target the muscles and nerve pathways involved in bowel movements
GLP-1s are most well studied for weight loss (obesity) and blood sugar control (type 2 diabetes)
By rotating your injection sites and following best practices, you can minimize discomfort and ensure the best possible results
In clinical trials, patients lost 12 percent of their body weight on average, in line with the original Ozempic injection, but a smidge lower than Mounjaro, Zepbound, and some of the more recent entries into this drug class